the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper

See also
Status	Clinical Trial	Phase
Completed	`NCT04079140` - Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion	Phase 4
Not yet recruiting	`NCT04301349` - Dinoprostone vs Misoprostol Before LNG-IUD Insertion	Phase 3
Recruiting	`NCT06335823` - Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology	N/A
Completed	`NCT03499743` - Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT04079140 - Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion

Phase 4

Not yet recruiting

NCT04301349 - Dinoprostone vs Misoprostol Before LNG-IUD Insertion

Phase 3

Recruiting

NCT06335823 - Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology

N/A

Completed

NCT03499743 - Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04312048
Study type	Interventional
Source	Cairo University
Contact
Status	Completed
Phase	Phase 3
Start date	April 15, 2020
Completion date	November 30, 2020

the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper Intrauterine Device Insertion

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms